Camargo Pharmaceutical Services

• Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

  Collaborator, Phase 2, Completed, 22 people, Mar 19, 2009

• Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

  Collaborator, Phase 1, Completed, 4 people, Mar 18, 2009

Sources: clinicaltrials.gov